Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0314555 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jennifer M Kwan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, American Heart Association, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
There is an urgent need to better understand the diverse presentations, risk factors, and outcomes of immune checkpoint inhibitor (ICI)-associated cardiovascular toxicity. There remains a lack of consensus surrounding cardiovascular screening, risk stratification, and clinical decision-making in patients receiving ICIs.
Methods
We conducted a single center retrospective cohort study including 2165 cancer patients treated with ICIs between 2013 and 2020. The primary outcome was adverse cardiovascular events (ACE): a composite of myocardial infarction, coronary artery disease, stroke, peripheral vascular disease, arrhythmias, heart failure, valvular disease, pericardial disease, and myocarditis. Secondary outcomes included all-cause mortality and the individual components of ACE. We additionally conducted an imaging substudy examining imaging characteristics from echocardiography (echo) and cardiac magnetic resonance (CMR) imaging.
Results
In our cohort, 44% (n = 962/2165) of patients experienced ACE. In a multivariable analysis, dual ICI therapy (hazard ratio [HR] 1.23, confidence interval [CI] 1.04–1.45), age (HR 1.01, CI 1.00–1.01), male sex (HR 1.18, CI 1.02–1.36), prior arrhythmia (HR 1.22, CI 1.03–1.43), lung cancer (HR 1.17, CI 1.01–1.37), and central nervous system (CNS) malignancy (HR 1.23, CI 1.02–1.47), were independently associated with increased ACE. ACE was independently associated with a 2.7-fold increased risk of mortality ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
- Yale University School of Medicine, New Haven, Connecticut, United States of America.
- Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
- Nuvance Health, Danbury, Connecticut, United States of America.
- Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
- Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, United States of America.
ORCID-Profile: Miles Shen, James L Cross, Lauren A Baldassarre
Förderung
- NCATS NIH HHS
- American Heart Association
- National Center for Advancing Translational Sciences
Zitieren
APA
Kwan, J. M., Shen, M., Akhlaghi, N., Hu, J. R., Mora, R., Cross, J. L., Jiang, M., Mankbadi, M., Wang, P., Zaman, S., Lee, S., Im, Y., Feher, A., Liu, Y. H., Ma, S. S., Tao, W., Wei, W., & Baldassarre, L. A. (2024). Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors. PLOS ONE. https://doi.org/10.1371/journal.pone.0314555
Vancouver
Kwan JM, Shen M, Akhlaghi N, Hu JR, Mora R, Cross JL, et al. Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors. PLOS ONE. 2024. doi:10.1371/journal.pone.0314555
BibTeX
@article{Kwan2024,
author = {Kwan, Jennifer M and Shen, Miles and Akhlaghi, Narjes and Hu, Jiun-Ruey and Mora, Ruben and Cross, James L and Jiang, Matthew and Mankbadi, Michael and Wang, Peter and Zaman, Saif and Lee, Seohyuk and Im, Yunju and Feher, Attila and Liu, Yi-Hwa and Ma, Shuangge S and Tao, Weiwei and Wei, Wei and Baldassarre, Lauren A},
title = {Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0314555}
}
EUVIMED